{"title":"逆转录酶抑制剂:对抗COVID-19的潜在药物输送","authors":"S. Deshpande, D. P. Mali","doi":"10.18231/J.IJPCA.2020.026","DOIUrl":null,"url":null,"abstract":"As the development of any drug and that too antiviral drug always requires time, in this Corona virus pandemic no specific drugs have been approved for coronavirus disease 2019 (COVID-19) till date. Therefore, assessment, analysis and use of currently available antiviral drugs become a challenge for medical field for a timely response to the current pandemic. Here, we have tried review anti CoV-2 potencies of available reverse transcriptase antiviral drugs. Several clinical trials are going on worldwide on variety of options but no specific solution in the form of vaccine or drug developed.\n\nKeywords: COVID 19, SARS, Remdesivir.","PeriodicalId":14317,"journal":{"name":"International Journal of Pharmaceutical Chemistry","volume":"32 1","pages":"161-165"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Reverse transcriptase inhibitors: Potential drug delivery combating COVID-19\",\"authors\":\"S. Deshpande, D. P. Mali\",\"doi\":\"10.18231/J.IJPCA.2020.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As the development of any drug and that too antiviral drug always requires time, in this Corona virus pandemic no specific drugs have been approved for coronavirus disease 2019 (COVID-19) till date. Therefore, assessment, analysis and use of currently available antiviral drugs become a challenge for medical field for a timely response to the current pandemic. Here, we have tried review anti CoV-2 potencies of available reverse transcriptase antiviral drugs. Several clinical trials are going on worldwide on variety of options but no specific solution in the form of vaccine or drug developed.\\n\\nKeywords: COVID 19, SARS, Remdesivir.\",\"PeriodicalId\":14317,\"journal\":{\"name\":\"International Journal of Pharmaceutical Chemistry\",\"volume\":\"32 1\",\"pages\":\"161-165\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutical Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/J.IJPCA.2020.026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/J.IJPCA.2020.026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Reverse transcriptase inhibitors: Potential drug delivery combating COVID-19
As the development of any drug and that too antiviral drug always requires time, in this Corona virus pandemic no specific drugs have been approved for coronavirus disease 2019 (COVID-19) till date. Therefore, assessment, analysis and use of currently available antiviral drugs become a challenge for medical field for a timely response to the current pandemic. Here, we have tried review anti CoV-2 potencies of available reverse transcriptase antiviral drugs. Several clinical trials are going on worldwide on variety of options but no specific solution in the form of vaccine or drug developed.
Keywords: COVID 19, SARS, Remdesivir.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
